Ortivus AB ser. B (ORTIb)

Currency in SEK
1.740
0.000(0.00%)
Closed·
ORTIb is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.7001.740
52 wk Range
0.8022.140
Key Statistics
Prev. Close
1.74
Open
1.7
Day's Range
1.7-1.74
52 wk Range
0.802-2.14
Volume
2.41K
Average Volume (3m)
7.65K
1-Year Change
41.4634%
Book Value / Share
0.24
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ORTIb Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Not profitable over the last twelve months

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy

Earnings

Latest Release
07/05/2026
EPS / Forecast
-0.02 / --
Revenue / Forecast
21.49M / --
EPS Revisions
Last 90 days

Compare ORTIb to Peers and Sector

Metrics to compare
ORTIb
Peers
Sector
Relationship
P/E Ratio
−7.4x25.9x−0.4x
PEG Ratio
−0.18−0.390.00
Price/Book
7.3x2.0x2.6x
Price / LTM Sales
2.0x1.9x3.0x
Upside (Analyst Target)
-78.0%53.5%
Fair Value Upside
Unlock23.7%9.0%Unlock

Ortivus AB (publ) develops and commercializes medical technology solutions and e-health for healthcare industry in Sweden and internationally. The company offers MobiMed Monitor that monitor and shares vital signs and ECG; MobiMed ePR, an electronic patient record system for documentation of treatment and events; MobiMed enRoute, a navigation, case management, and mass casualty management; MobiMed FleetCtrl, a a software application that regular controls, checklists, and documentation tailored for seamless fleet management; MobiMed Life, a heart safe solution. It also provides emergency medical services, primary care, and rescue services. The company was founded in 1985 and is headquartered in Danderyd, Sweden. Ortivus AB (publ) is a subsidiary of Ponderus Invest AB.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
1.60M1.80%2.78M
Other Institutional Investors
79.45M89.72%138.25M
Public Companies & Retail Investors
7.50M8.47%13.06M
Total
88.55M100.00%154.08M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Tapira Investment AB80.36%71,164,116123,826
Nordnet AB (publ)5.00%4,426,6997,702

FAQ

What Is the Ortivus B (Stockholm: ORTIb) Share Price Today?

The Ortivus B stock price today is 1.740 SEK.

What Stock Exchange Does Ortivus B (ORTIb) Trade On?

Ortivus B is listed and trades on the Stockholm Stock Exchange.

What Is the Ticker (Stock Symbol) for Ortivus B?

The stock symbol (also called a 'ticker') for Ortivus B is "ORTIb."

What Is the Current Ortivus B Market Capitalisation?

As of today, Ortivus B (Stockholm: ORTIb) market cap is 154.300M SEK.

What Is Ortivus B's (ORTIb) Earnings Per Share (TTM)?

The Ortivus B EPS is currently -0.332 (Trailing Twelve Months).

Is ORTIb a Buy or Sell From a Technical Analyst Perspective?

Based on today's Ortivus B moving averages and other technical indicators, the daily buy/sell signal for ORTIb stock is Neutral.

How Many Times Has Ortivus B Stock Split?

Ortivus B has split 4 times. (See the ORTIb stock split history page for full effective split date and price information.)

How Many Employees Does Ortivus B Have?

Ortivus B has 34 employees, based on their latest Companies House report.

What is the current trading status of Ortivus B (Stockholm: ORTIb)?

As of 19/07/2026, Ortivus B (ORTIb) is trading at a share price of 1.740 SEK, with a previous close of 1.740 SEK. The stock has fluctuated within a day range of 1.700 SEK to 1.740 SEK, while its 52-week range spans from 0.802 SEK to 2.140 SEK.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.